Product Information
MINOCYCLINE HCL 50 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.3435 per EA under NDC 64380015401. Its NADAC has been published 217 times since Aug 10, 2022.
FDA first approved this application on Apr 16, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380015401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065131FDA Approved
4/16/2003
TE Code
AB
On Market Since
4/11/2022
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE HCL 50 MG TABLET has been published 217 times since Aug 10, 2022, and over the history we have for it it has declined 64.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3435 per EA |
|---|---|
| All-time high | $1.1685 (May 10, 2023) |
| All-time low | $0.2336 (Jun 19, 2024) |
| 52-week high | $0.4484 |
| 52-week low | $0.3435 |
| Median price | $0.4044 |
| Average price | $0.5149 |
| Largest weekly change | -68.0% (May 17, 2023) |
| Weeks tracked | 217 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Minocycline Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Minocycline Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MINOCYCLINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE HCL 50 MG TABLET, manufactured by Strides Pharma Inc., is $0.3435 per EA (NDC 64380015401), effective Sep 30, 2026.
How has the price of MINOCYCLINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE HCL 50 MG TABLET has declined 64.5%. It has been tracked across 217 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE HCL 50 MG TABLET?
Since Aug 10, 2022, the NADAC for MINOCYCLINE HCL 50 MG TABLET has ranged from a low of $0.2336 (Jun 19, 2024) to a high of $1.1685 (May 10, 2023), with a median of $0.4044 per EA.
Are there cheaper alternatives to MINOCYCLINE HCL 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MINOCYCLINE HCL 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MINOCYCLINE HCL 50 MG TABLET?
MINOCYCLINE HCL 50 MG TABLET (NDC 64380015401) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.